SLC1A5 and cardiovascular disorder: Additionally, Westerman et al. (2019) discovered a region in SLC1A5 (chr19:47287777–47288263) to be differentially methylated with respect to incident cardiovascular disease in the Women’s Health Initiative cohort, with results replicated in the Framingham Heart Study [74].